Table 1 Splenocyte immunophenotypes after treatment with Pioglitazone in vitro and in vivo

14.4 % ± 0.4

17.8 % ± 1.0*

86.4 % ± 2.8

86.2 % ± 0.5

10.7 % ± 3.0*

64.3 % ± 3.3*

12.7 % ± 0.7

3.7 % ± 0.3^#

53.1 % ± 10

50.0 % ± 8.8

11 % ± 8.4^#

27.3 % ± 3.9^#

6.6 % ± 0.4

33.1 % ± 3.4^¶

12.4 % ± 1.8

19.0 % ± 0.5

4.6 % ± 2.1^¶

36.2 % ± 7.1^¶